313278-90-9

Basic information

• Product Name: methyl 2-N-(trifluoroacetyl)amino-3-nitrobenzoate
• Synonyms: methyl 2-N-(trifluoroacetyl)amino-3-nitrobenzoate
• CAS NO: 313278-90-9
• Molecular Weight: 292.171
• Mol File: 313278-90-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl 2-N-(trifluoroacetyl)amino-3-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-N-(trifluoroacetyl)amino-3-nitrobenzoate(313278-90-9)
• EPA Substance Registry System: methyl 2-N-(trifluoroacetyl)amino-3-nitrobenzoate(313278-90-9)

Safety Data

• Hazardous Substances Data: 313278-90-9(Hazardous Substances Data)

Upstream product

• 77326-45-5 2-carbamoyl-3-nitrobenzoic acid 
• 606-18-8 3-nitroanthranilic acid 
• 57113-91-4 methyl 3-nitroanthranilate 
• 407-25-0 trifluoroacetic anhydride 

Downstream Products

• 948350-76-3 2-[(4-bromo-benzyl)-(2,2,2-trifluoro-acetyl)amino]-3-nitrobenzoic acid methyl ester 
• 313278-92-1 methyl 2-trifluoromethyl-1H-benzimidazole-4-carboxylate 

Relevant articles and documents

NOVEL DUAL ACTION RECEPTORS ANTAGONISTS (DARA) AT THE AT1 AND ETA RECEPTORS

The present invention relates to new compounds of the formula [Chemical formula should be inserted here. Please see paper copy] wherein R1, R2, R3, and R31 are as specified herein. The invention also relates to a method for preparation thereof, as well as combinations of the new compounds with previously known agents. The invention also relates to the use of the above-mentioned compounds and combinations for the preparation of a medicament for treating hypertension of different kinds, alleviating organ damage of different kinds, treating or preventing diabetic nephropathy, treating endothelin and angiotensin mediated disorders, and treating prostate cancer.